Mechanistically, IGF2BP3 activates Notch3 signaling by maintaining NOTCH3 mRNA stability in an m6A-dependent manner, thus enhancing the tumor-initiating ability of DTCs and promoting the development of metastasis. This evidence concerns the gene NOTCH3 and neoplasm.